medical waste treatment
Scope
Date
~
-
Healthcare
Korea’s booming medical tourism: Skin care, plastic surgery in demand
The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...
11 HOURS AGO
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
ESG
HD Hyundai, Hyundai Dept. Store to co-work for recycling plastic waste
South Korea's HD Hyundai Oil Bank Co. and Hyundai Department Store Co. have partnered to create a closed-loop plastic film recycling system, a first...
Apr 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Remsima SC in Denmark
South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...
Apr 19, 2024 (Gmt+09:00)
-
Future mobility
Hyundai, Toray to team up to develop mobility materials
Hyundai Motor Group said on Thursday it has signed a strategic partnership agreement with Japan's Toray Industries Inc. to jointly develop carbon fi...
Apr 18, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
LG Elec, Microsoft, GE to collaborate for smart hospital
LG Electronics Inc. announced on Thursday that it signed a memorandum of understanding (MOU) with GE Healthcare Korea and Microsoft (MS) Korea to co...
Apr 12, 2024 (Gmt+09:00)
-
Chemical Industry
LG Chem, Ansan City to team up for waste vinyl recycling
South Korea's LG Chem Ltd. has decided to recycle waste vinyl generated in Ansan, Gyeonggi Province, into plastic raw materials. The company announc...
Apr 03, 2024 (Gmt+09:00)
-
Batteries
Doosan joins hands with China’s CNGR for battery recycling
South Korea’s plant and machinery powerhouse Doosan Group has teamed up with China’s CNGR Advanced Material Co. to expand its electric v...
Mar 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Genesystem enters Indian tuberculosis treatment market
Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kit...
Mar 27, 2024 (Gmt+09:00)
-
Bio & Pharma
Reversing age possible in a decade: Harvard Prof. David Sinclair
Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, abou...
Mar 18, 2024 (Gmt+09:00)
-
Waste management
Korea Zinc, LG Chem team up for US recycling business
Korea Zinc Inc., the leading global zinc and lead smelter, and LG Chem Ltd., South Korea’s top petrochemical producer, joined hands for the pl...
Mar 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Vivid Health gets seed round from Kakao Ventures
Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investme...
Mar 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion ships initial supply of Zymfentra to US
South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...
Feb 29, 2024 (Gmt+09:00)
-
Bio & Pharma
SK C&C wins Korea’s nod for brain infarct diagnosis AI solution
SK Inc C&C (SK C&C), the information technology service unit of South Korea’s SK Group, said on Thursday it has secured medical device...
Feb 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis to supply Hadlima to US government
South Korea’s Samsung Bioepis and the US-based Organon, the local partner company of Samsung group's biopharmaceutical research and developmen...
Feb 21, 2024 (Gmt+09:00)
-
Artificial intelligence
Kakao Brain releases medical GenAI tech for free
Kakao Brain, an artificial intelligence (AI) R&D subsidiary of South Korea's Kakao Corp., announced on Tuesday that it has uploaded the Labeler ...
Feb 20, 2024 (Gmt+09:00)
-
Economy
Korea's job growth at 10-month high despite weak youth employment
South Korea’s job increases rose for a second straight month to a 10-month high in January thanks to higher employment of the older, although ...
Feb 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...
Feb 15, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom to enter Australian pet clinics market in H1
South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...
Feb 13, 2024 (Gmt+09:00)
-
Korean Investors
Samsung Asset to launch S.Korea's first obesity treatment ETF
Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...
Feb 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Chemical Industry
SK Chemicals targets US medical packaging market
South Korea's SK Chemicals Co. is targeting the US medical packaging market with its circular recycling materials. Circular recycling is SK Chemical...
Feb 01, 2024 (Gmt+09:00)
-
Korean chipmakers
No annual bonuses for Samsung chip unit due to loss
Samsung Electronics Co., the world’s top memory chipmaker, decided not to pay annual bonuses to staff of its semiconductor business due to the...
Jan 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Airlines
Asiana, Korea Univ. to jointly attract medical tourism
South Korea's Asiana Airlines Inc. announced on Monday that it has partnered with Korea University Anam Hospital to promote medical tourism. The agr...
Jan 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)